Patterns of care and survival impact of adjuvant chemoradiotherapy for oropharyngeal cancer with intermediate-risk features.
Alexander N GoelSophia SangarLaith MukdadChase M HeatonWilliam R RyanMarilene B WangJennifer L LongMaie A St JohnPublished in: Head & neck (2019)
Despite high rates of utilization, aCRT is not associated with better survival vs aRT for OPSCC with intermediate-risk features, including HPV-negative tumors.